Technology Commercialization Workshop
Date: May 30, 2009
Time: 7:30 am - 3 pm
Place: Hotel Zaza, 5701 Main Street,
Houston, Texas 77005
Scope:
NSBRI is committed to facilitating the application of its funded space-related research to benefit life on earth. One avenue is to familiarize its academic researchers with the steps required to successfully move scientific discoveries from bench to market and to provide access to business experts and the investor community.
NSBRI Industry Forum enlisted a team of local and out-of-town business leaders to present lectures that address certain germane topics such as entrepreneur lessons learned, Intellectual property protection, effective communication with university technology transfer offices, ethical conflicts of interest, gap funding for applied research and business development activities, and production and regulatory considerations.
NSBRI-funded investigators with advanced research programs were invited to attend and network. The speaker presentations and Q & A sessions were video-recorded and are posted below.
A survey of participants indicated that the return on their investment of time spent at the workshop was very good (score of 4 out of 5 possible points) and 100-percent said that they would return for a follow-on workshop. In addition, as a result of this one-day event, discussions between academic attendees and potential investors have taken place.
Program:
| |
Commercialization Workshop Sessions.
A 10 minute question and answer session follows each 20 minute presentation. |
7:30 am -
8:30 am |
Networking Breakfast: Déjà vu Room - Hotel ZaZa |
|
|
8:45 am -
9:00 am |
Opening Remarks |
Dorit Donoviel, Ph.D. |
NSBRI |
9:00 am -
9:30 am |
Serial Entrepreneur: Lessons Learned from the Trenches
View Webinar |
Joe Cunningham, M.D.
Prior to founding Santé Ventures, Joe was a healthcare Venture Partner with Austin Ventures and was previously the Vice Chair of the Ascension Health Ventures investment committee. He is also the former Chief Medical Officer of the Providence Health System and Executive Director of the 300-physician Providence Health Alliance, both of which belong to the Ascension Health system. Joe currently serves as a member of the Board of Trustees of the Texas Medical Association and of the Medical Advisory Board of Blue Cross Blue Shield of Texas. He has extensive management experience and is recognized nationally for his expertise in healthcare delivery systems, physician associations and compensation models. He is board certified in both Internal Medicine and Quality Assurance and Peer Review.Read Bio [+] |
Sante Ventures |
| |
SESSION I: TECHNOLOGY TRANSFER |
9:45 am -
10:15 am |
A Primer for Identifying and Protecting your Intellectual Property
View Webinar |
Bill Ramey, Esq
William (Bill) Ramey is an attorney in Winstead's Intellectual Property, Nanotechnology and Biotechnology practices. He has extensive experience in obtaining, enforcing and licensing intellectual property, including patents, trademarks, copyrights and trade secrets. Bill also has extensive technical and patent prosecution/preparation experience in the areas of oil field technology, high technology materials, inorganic and organic chemicals, polymers, chemical processing, agricultural chemicals and equipment, medical equipment, biotechnology, engineered structures and business methods. Bill has been involved in many patent, trade secret, trademark and copyright disputes. He has prepared numerous opinions on intellectual property rights regarding validity, infringement and freedom to operate, and he has written several hundred patents and prosecuted many more.
Prior to joining Winstead, Bill worked in private practice where he drafted and prosecuted patent applications, prior art searches and opinions, including patentability, non-infringement/ infringement, validity and freedom to practice. His representative technologies included biotech and pharmaceuticals, including biochemistry, cell immunology, small molecule and cell biology; mechanical, including oil field service tools, medical devices and other complex mechanical applications related to downhole applications and methods; chemical, including applications related to the polymer arts; and electrical, including computer programs and semiconductors. Bill also has experience working as a patent attorney for Akzo Nobel and its companies, where he worked on due diligence for assessing portfolios for acquisition of new technologies and assessing the patent positions of the entities for acquisition, negotiating and reviewing contracts, coordinating outside counsel, conducting training conferences on intellectual property and training on Abbreviated New Drug Application (ANDA) procedures.Read Bio [+] |
Winstead PC |
10:20 am -
10:50 am |
Licensing from Academic Institutions
View Webinar |
Paul Campbell, Ph.D.
Paul Campbell is currently Director of investments at DFJ Mercury and has significant experience in the materials and bioscience sectors, with a particular focus on industrial and agricultural biotechnology. Prior to joining DFJ Mercury, Paul co-founded and was President of Aster Bio, a Houston-based biotech company providing bacteria and bacterial blends for the bioremediation, wastewater, and agricultural industries. Also an active member of the Houston life sciences entrepreneurial ecosystem, Paul interned at the Houston Technology Center where he helped start-up companies define business and operational strategies and develop and refine investor presentations and business plans. Paul received his B.S. from Duke University, and earned a Ph.D. in Biochemistry and Cell Biology from Rice University, and an MBA from the Jones Graduate School of Management at Rice University.
Paul is a co-founder of GlycosBio and is currently serving as its chief science officer. Paul also serves on the Houston Technology Center's Life Science Screening Committee, and is a member of BioHouston.
Read Bio [+] |
DFJ Mercury |
10:50 am -
11:00 am |
Coffee Break |
|
|
11:15 am -
11:45 am |
Conflicts of Interests and Ethical Issues
View Webinar |
Laura Sanger-Kelly, Esq.
Laura Sanger-Kelly is currently Senior Policy Analyst at Baylor College of Medicine's Research Compliance Office. She received her Bachelor of Science in Biological Sciences from the University of Houston at Clear Lake in 1983; she received her Master of Science degree in Chemistry, with special emphasis on organometallic chemistry, from the University of Houston at Clear Lake in 1991. She co-founded an independent oncology laboratory in the 1990's, which manufactured an FDA-approved medical device. While there she assisted in maintaining CLIA and Texas Department of Health certifications, as well as performing management duties and assisting in laboratory operations. In 1996 she received her Doctor of Jurisprudence degree from the University of Houston Law Center, where she studied corporate and securities law, intellectual property, and space law. She is currently a candidate for an LL.M. in Health Law from the University of Houston Law Center.Read Bio [+] |
Baylor College of Medicine |
12:00 pm -
1:00 pm |
Networking Lunch: Déjà vu Room - Hotel ZaZa |
|
|
| |
SESSION II: PANEL DISCUSSION |
1:00 pm -
1:50 pm |
Business Development - Gap Funding, Services, and Matchmaking
View Webinar
View Webinar
View Webinar |
Tim Gerrity, Ph.D.
Tim Gerrity is Director of the Office of Technology Transfer and Commercialization at California State University San Bernardino and is the founding Director of the new Alliance for Commercialization of Technology - A Southern California initiative to assist new high technology companies commercialize their innovations. Dr. Gerrity has held multiple positions in academia, government, and industry focusing respectively on translational medical research, science and technology management and policy, and medical device commercialization. As a pulmonary physiologist at the University of Illinois at Chicago, and later at the US Environmental Protection Agency, he pioneered new methods for diagnosing human lung diseases and assessing the human health impacts of air pollution. He subsequently was appointed to successively more responsible positions within the Office of Research and Development (ORD) at the US Department of Veterans Affairs in Washington, DC, where he became the Assistant Chief R&D Officer. ORD manages VA's $1 billion national research programs in medical, health services, and rehabilitation research. Dr. Gerrity went on to co-found two nationally recognized biomedical technology research centers at Georgetown University and Worcester Polytechnic Institute. He has also served as a consultant to the medical device industry in Massachusetts. Along with his experience in government and industry, Dr. Gerrity has held academic positions in the schools of medicine of the University of Illinois at Chicago, University of North Carolina, Chapel Hill, and Georgetown University; and in the Biomedical Engineering Department at WPI. He has published over 60 peer-reviewed papers in journals such as the New England Journal of Medicine, Journal of Applied Physiology, and IEEE Transactions in Biomedical Engineering.
He received his B.S., M.S., and Ph.D. degrees in Physics at the University of Illinois at Chicago, and received post-doctoral training in pulmonary physiology at University of Illinois at Chicago School of Medicine.Read Bio [+] |
California State San Bernadino |
Susan Zelicoff
Susan Zelicoff leads new business development and strategic planning consulting services at Advanced Manufacturing Technology Ventures (LMTV). Concurrent to this activity, Susan leads marketing and communications for the FirstLink program, which is the National Center of Excellence for First Responder Technology Transfer operated by Pittsburgh Gateways Corp. The mission for the Center is the transfer of Department of Defense technology that can bring new emergency first responder solutions to commercialization.
Ms. Zelicoff has over twenty years in technology commercialization, marketing, and strategic planning in industrial arenas. Leveraging a B.S. degree in chemistry and an M.B.A. in marketing, she has launched new products, technologies, and businesses for Air Products & Chemicals, Bayer Corporation, as well as for numerous small business and start-up entities.
Ms. Zelicoff is the former Managing Director for Elastomer Solutions, an industry-led dot.com start-up which provided eCommerce services to rubber buyers and sellers. Her strategic planning experience includes past support to major global business initiatives in polymers, chemicals, medical diagnostics, pharmaceuticals, and crop protection businesses.
An active supporter since its inception, Ms. Zelicoff now serves as Board Vice President at the Pittsburgh Glass Center, a comprehensive glass art studio dedicated to teaching, creating and promoting glass art.Read Bio [+] |
Advanced Manufacturing Technology Ventures, LLC |
| |
SESSION III: DEVELOPMENT AND MANUFACTURING |
1:55 pm -
2:25 pm |
Regulatory and Clinical Processes to Commercialization
View Webinar |
Jaye Thompson, Ph.D.
Jaye Thompson, Ph.D. is Senior Vice President of Clinical Operations at inVentive Clinical Solutions. She has more than 20 years of experience in the clinical research industry. In her current capacity, she is responsible for directing and managing all aspects of clinical trials managed through the Houston office of inVentive.
Prior to its acquisition by inVentiv, Dr. Thompson was President and Founder of SYNERGOS, Inc, a leading clinical research organization based in Houston, Texas. Under her leadership, SYNERGOS grew consistently year after year, gaining a reputation as one of the foremost clinical research organizations in the region. She started her career as a Biostatistician and Project Leader for Applied Logic Associates.
Dr. Thompson has advised a number of leading life science companies on strategic planning and clinical product development. She has directed and managed statistical analysis, data management, report writing, and conduct of clinical trials for a wide variety of indications. In addition, she has been actively involved in over 200 clinical trials for drugs, biologics, and devices. She has directed and managed the data management, statistical analysis and report writing for multiple FDA submissions, including 6 NDAs and 3 PMAs. Moreover, she frequently represents Sponsor companies at FDA meetings and advisory committee meetings and teleconferences.
Dr. Thompson holds a Bachelor's degree in Applied Mathematics from Texas A&M University and both an MS and a PhD in Biostatistics from the University of Texas Health Science Center in Houston. She serves on the Houston Technology Center's Life Sciences Screening Committee, the Houston Community College Biotech Advisory Committee, the Montgomery College Biotechnology Advisory Board, and the BioHouston Associate Advisory Board. She is also a member of the Society for Clinical Trials, the Drug Information Association, and the American Statistical Association.Read Bio [+] |
InVentive Clinical Solutions |
2:30 pm -
3:00 pm |
Manufacturing Prototypes and Production
View Webinar |
Albert Rodriguez
Albert Rodriguez is currently Director of Engineering with ThromboVision a Houston based biotech company developing platelet function monitoring technology. He has over 20 years of experience in the areas of technology development, project management, product development and strategic planning in a number of industries including medical device, communications, robotics, aerospace and software. Prior to joining ThromboVision, he was employed at Cyberonics as Sr. Manager, Design Engineering helping develop the latest neurostimulation technology for the treatment of various neurological disorders. Prior to that, Mr. Rodriguez was employed by McDonnell Douglas/Boeing where he was involved in the development of various systems currently used by NASA as well the satellite communication industry. He received his BS degree from the University of Houston in Computer Science with a concentration in Software Engineering.Read Bio [+] |
Thrombo Vision |
Workshop Director
Dorit Donoviel, Ph.D.
Senior Scientist
National Space Biomedical Research
Institute
One Baylor Plaza, NA-425
Houston, Texas 77030
Paul Campbell, Ph.D.
Director
DFJ Mercury
One Greenway Plaza
Suite 930
Houston, Texas 77046
Joe Cunningham, M.D., M.B.A.
Managing Director
Santé Ventures
401 Congress
Suite 2950
Austin, Texas 78701
Timothy Gerrity, Ph.D.
Director, Alliance for Commercialization of
Technology
California State University, San Bernardino
5500 University Parkway
San Bernardino, California 92407
William Ramey, Esq.
Attorney
Winstead PC
1100 JP Morgan Chase Tower
600 Travis Street
Houston, Texas 77002 |
Albert Rodriguez
Director of Engineering
ThromboVision
8036 El Rio
Houston, Texas 77054
Laura Sanger-Kelly, M.S., J.D., C.I.P.
Senior Policy Analyst
Baylor College of Medicine
Research Compliance Services
One Baylor Plaza
Houston, Texas 77030
Jaye Thompson, Ph.D.
Senior Vice President of Clinical
Operations
inVentiv Clinical Solutions, LLC
2202 Timberloch Place
Suite 230
The Woodlands, Texas 77380
Susan Zelicoff, M.B.A.
Executive Vice President
Advanced Manufacturing Technology
Ventures, LLC
Marketing Director, FirstLink
2000 Corporate Drive
Suite 300
Wexford, Pennsylvania 15090 |
back |
